PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Definition • Vendor segmentation • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Global ED treatment market by product • Global ED drugs market • Global ED devices market PART 07: Market segmentation by type of ED drugs • Global ED treatment market by type of ED drugs PART 08: Market segmentation by type of ED device • Global ED treatment market by type of ED device PART 09: Geographical segmentation • Global ED treatment market by geography • ED treatment market in Americas • ED treatment market in EMEA • ED treatment market in APAC PART 10: Market drivers PART 11: Impact of drivers PART 12: Market challenges PART 13: Impact of drivers and challenges PART 14: Market trends PART 15: Vendor landscape • Competitive scenario PART 16: Key vendor analysis • Bayer • Boston Scientific • Coloplast • Eli Lilly • Pfizer • Other prominent vendors PART 17: Appendix • List of abbreviations PART 18: Explore Technavio List of Exhibits Exhibit 01: Global erectile dysfunction treatment market by product Exhibit 02: Key countries Exhibit 03: Product offerings Exhibit 04: Major causes of ED Exhibit 05: Global ED treatment market 2015-2020 ($ billions) Exhibit 06: Key drug patent expirations in major countries Exhibit 07: Five forces analysis Exhibit 08: Global ED treatment market by product 2015 and 2020 Exhibit 09: Global ED treatment market by product 2015-2020 Exhibit 10: Global ED drugs market 2015-2020 ($ billions) Exhibit 11: Global ED devices market 2015-2020 ($ millions) Exhibit 12: ED device market by geography 2015 and 2020 Exhibit 13: Global ED treatment market by type of ED drugs 2015 Exhibit 14: Global ED treatment market by type of ED device 2015 and 2020 Exhibit 15: Global ED treatment market by geography 2015 and 2020 Exhibit 16: Global ED treatment market by geography 2015-2020 ($ millions) Exhibit 17: ED treatment market in Americas 2015-2020 ($ billions) Exhibit 18: ED treatment market in Americas by drugs and devices Exhibit 19: ED treatment market in EMEA 2015-2020 ($ billions) Exhibit 20: Occurrence of ED by age 2015 Exhibit 21: ED treatment market in EMEA by drugs and devices 2015 and 2020 Exhibit 22: ED treatment market in APAC 2015-2020 ($ millions) Exhibit 23: ED treatment market in APAC by drugs and devices 2015 and 2020 Exhibit 24: ED treatment Market by product across regions 2015 and 2020 ($ million) Exhibit 25: Estimated cancer cases and deaths in US 2016 (thousands) Exhibit 26: Chances of men developing ED by age in the US Exhibit 27: Number of individuals with diabetes around the world 2015 and 2040 (millions) Exhibit 28: Impact of drivers Exhibit 29: Impact of drivers and challenges Exhibit 30: Bayer: Key takeaways Exhibit 31: Boston Scientific: Key takeaways Exhibit 32: Coloplast: Key takeaways Exhibit 33: Eli Lilly: Key takeaways Exhibit 34: Pfizer: Key takeaways

Bayer, Boston Scientific, Coloplast, Eli Lilly, Pfizer, Apricus Biosciences, Cristalia Produtos Quimicos Farmaceuticos, Dong-A Socio, Endo Pharmaceuticals, Futura Medical, Meda Pharmaceuticals, Promedon, SK Chemical, Teva Pharmaceuticals, Vivus, and Zephyr Surgical Implants (ZSI).